Legal The information on this site has been developed by Osteoporosis Canada in consultation with its Scientific Advisory Council. This Council is composed of leading Canadian medical and scientific experts […]

Dr. Suzanne Morin has been named a member of the Canadian Institutes of Health Research (CIHR) Institute of the Musculoskeletal Health and Arthritis Advisory Board. In this capacity Dr. Morin […]

As we work to adjust to our new normal during COVID-19, now more than ever, staying fracture-free is critical for anyone with osteoporosis. Healthcare systems are over-stretched, with general recommendations […]

Osteoporosis Canada (OC) is pleased to announce the updated version of “Key performance indicators (KPIs) for Canadian FLSs (v2.0)”. Version 2 of the OC FLS KPIs brings in new learnings […]

IMPACT REPORT 2018 – 2019 PATIENT STORY: MEET BRUCE SCAFE On the day after Bruce’s 60th birthday, he ran his very first marathon. It was months of training for the […]

Osteoporosis Canada is saddened to announce the passing of Dr. Timothy M. Murray, founding member of Osteoporosis Canada. Dr. Murray was the Emeritus Professor of Medicine at the University of […]

Latest News Sandoz receives Health Canada approval for Jubbonti®, first and only denosumab biosimilar for treatment of osteoporosis. May 31, 2024 Health Canada has provided authorization to market Jubbonti® (denosumab […]

Vitamin D is an essential nutrient for proper growth and formation of teeth and bones. We need vitamin D for the absorption of calcium and phosphorus from the foods that […]

Our Senior Team Dr. Famida Jiwa President and CEO Dr. Jiwa is the President and CEO of Osteoporosis Canada, and has been with the organization since 2006. Prior to joining […]